Bayer's Elevit and Latest Research on Maternal Gut Health at 62nd Annual Conference
On July 14, 2026, Bayer HealthCare, known for its leading pregnancy and prenatal supplement brand Elevit®, co-hosted a lunch seminar at the 62nd Annual Conference on Perinatal and Neonatal Medicine, held at PACIFICO Yokohama. The seminar focused on the significant theme of 'The Impact of Maternal Gut Microbiota on Infants during Pregnancy and Postpartum'.
The event took place from 12:10 PM to 1:10 PM and was dedicated to exploring how maternal health directly influences the gut microbiome development of infants, which has longstanding implications on their health and immunity. Two keynote presentations highlighted the critical factors that shape infants' gut microbiota early in life.
Chaired by Dr. Shinji Katsuragi, a leading professor of obstetrics and gynecology at Miyazaki University, this presentation was delivered by Dr. Kazunari Kaneko, a leading pediatric professor at Kansai Medical University. The discussion revolved around groundbreaking research indicating that the gut microbiota, formed shortly after birth, plays a foundational role in lifelong health, particularly through the production of short-chain fatty acids that contribute to immune system maturation and gut barrier functions. Researchers are increasingly recognizing that disturbances in this microbiota can be linked to various health challenges, including allergies, obesity, and diabetes.
Dr. Kaneko emphasized the first 1,000 days of life, particularly from conception to two years of age, as a crucial period for not only the development of brain and metabolic functions but also for gut microbiota formation. This period's nutritional status and living environment can significantly influence future health outcomes. Furthermore, consideration of maternal gut microbiota is vital in understanding how modes of delivery and breastfeeding methods impact infant microbiome development. Recommendations were also made for maintaining healthy gut environments through probiotic and prebiotic-rich diets and supplements.
Chaired by Dr. Akihito Nakai, Vice President of the Japan Society of Obstetrics and Gynecology and head of the Childcare Station of the Aikyu Postpartum Care Facility, this presentation discussed recent increases in allergic diseases. Dr. Hideaki Morita, head of the Immunology, Allergy, and Infectious Disease Research Section at the National Center for Child Health and Development, explained how genetic predispositions interact with environmental factors to influence increased allergy risks.
The discussion referenced the 'hygiene hypothesis' which suggests reducing exposure to diverse microorganisms during childhood correlates with heightened allergy risks, as well as the 'epithelial barrier hypothesis,' linking skin and mucus barrier dysfunctions to allergies. Dr. Morita also elaborated on the concept of 'allergic march,' where conditions such as atopic dermatitis progress to food allergies and asthma, underlining the need for preventive measures against atopic dermatitis in early childhood. He presented findings from international studies highlighting the correlation between probiotic intake by mothers during pregnancy and postpartum, and the potential impact on reducing allergic conditions in offspring.
This seminar provided a comprehensive understanding of how nutritional status and living environments from perinatal through early childhood could influence the development of the gut microbiota and immune systems, ultimately enhancing future health prospects. Elevit® continues to advocate for the health and well-being of women through every stage of life—from conception through pregnancy and postpartum—by disseminating essential nutritional information and support.
In conjunction with the seminar, Elevit set up a brand booth at the conference, showcasing the recently launched 'Elevit® Probiotics' available since July 29, 2026. The booth highlighted various products catering to different life stages including 'Elevit®' prenatal multivitamins, 'Menavit®' for men, 'Elevit® Plant-based DHA,' and 'Elevit® Postpartum Care,' emphasizing support for maternal and child health throughout the critical first 1,000 days of life.
The 62nd Annual Conference on Perinatal and Neonatal Medicine took place from July 12 to July 14, 2026, at PACIFICO Yokohama, with a strong focus on perinatal health advancements and practices. The event served as a platform for experts to share vital research insights and clinical practices related to neonatal and maternal care. For more details, the conference website can be visited at link.
Elevit® specifically caters to the nutritional needs of Japanese women before, during, and after pregnancy, providing key vitamins and minerals such as magnesium and folic acid. Each product is formulated to support optimal health outcomes for mothers and children during these critical periods. For further information about Elevit and their family of products, consider visiting their websites and social media platforms.
Seminar Overview
The event took place from 12:10 PM to 1:10 PM and was dedicated to exploring how maternal health directly influences the gut microbiome development of infants, which has longstanding implications on their health and immunity. Two keynote presentations highlighted the critical factors that shape infants' gut microbiota early in life.
Presentation 1: Maternal Influence on Gut Microbiota from Fetal to Infant Stage
Chaired by Dr. Shinji Katsuragi, a leading professor of obstetrics and gynecology at Miyazaki University, this presentation was delivered by Dr. Kazunari Kaneko, a leading pediatric professor at Kansai Medical University. The discussion revolved around groundbreaking research indicating that the gut microbiota, formed shortly after birth, plays a foundational role in lifelong health, particularly through the production of short-chain fatty acids that contribute to immune system maturation and gut barrier functions. Researchers are increasingly recognizing that disturbances in this microbiota can be linked to various health challenges, including allergies, obesity, and diabetes.
Dr. Kaneko emphasized the first 1,000 days of life, particularly from conception to two years of age, as a crucial period for not only the development of brain and metabolic functions but also for gut microbiota formation. This period's nutritional status and living environment can significantly influence future health outcomes. Furthermore, consideration of maternal gut microbiota is vital in understanding how modes of delivery and breastfeeding methods impact infant microbiome development. Recommendations were also made for maintaining healthy gut environments through probiotic and prebiotic-rich diets and supplements.
Presentation 2: Environmental Factors and Allergic Diseases in Mother and Child
Chaired by Dr. Akihito Nakai, Vice President of the Japan Society of Obstetrics and Gynecology and head of the Childcare Station of the Aikyu Postpartum Care Facility, this presentation discussed recent increases in allergic diseases. Dr. Hideaki Morita, head of the Immunology, Allergy, and Infectious Disease Research Section at the National Center for Child Health and Development, explained how genetic predispositions interact with environmental factors to influence increased allergy risks.
The discussion referenced the 'hygiene hypothesis' which suggests reducing exposure to diverse microorganisms during childhood correlates with heightened allergy risks, as well as the 'epithelial barrier hypothesis,' linking skin and mucus barrier dysfunctions to allergies. Dr. Morita also elaborated on the concept of 'allergic march,' where conditions such as atopic dermatitis progress to food allergies and asthma, underlining the need for preventive measures against atopic dermatitis in early childhood. He presented findings from international studies highlighting the correlation between probiotic intake by mothers during pregnancy and postpartum, and the potential impact on reducing allergic conditions in offspring.
This seminar provided a comprehensive understanding of how nutritional status and living environments from perinatal through early childhood could influence the development of the gut microbiota and immune systems, ultimately enhancing future health prospects. Elevit® continues to advocate for the health and well-being of women through every stage of life—from conception through pregnancy and postpartum—by disseminating essential nutritional information and support.
In conjunction with the seminar, Elevit set up a brand booth at the conference, showcasing the recently launched 'Elevit® Probiotics' available since July 29, 2026. The booth highlighted various products catering to different life stages including 'Elevit®' prenatal multivitamins, 'Menavit®' for men, 'Elevit® Plant-based DHA,' and 'Elevit® Postpartum Care,' emphasizing support for maternal and child health throughout the critical first 1,000 days of life.
Conference Highlights
The 62nd Annual Conference on Perinatal and Neonatal Medicine took place from July 12 to July 14, 2026, at PACIFICO Yokohama, with a strong focus on perinatal health advancements and practices. The event served as a platform for experts to share vital research insights and clinical practices related to neonatal and maternal care. For more details, the conference website can be visited at link.
About Elevit®
Elevit® specifically caters to the nutritional needs of Japanese women before, during, and after pregnancy, providing key vitamins and minerals such as magnesium and folic acid. Each product is formulated to support optimal health outcomes for mothers and children during these critical periods. For further information about Elevit and their family of products, consider visiting their websites and social media platforms.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.